Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,915 Million (Mid Cap)
52.00
NA
4.34%
-0.25
3.89%
1.62
Revenue and Profits:
Net Sales:
602 Million
(Quarterly Results - Dec 2025)
Net Profit:
94 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.27%
0%
5.27%
6 Months
-6.57%
0%
-6.57%
1 Year
10.87%
0%
10.87%
2 Years
9.07%
0%
9.07%
3 Years
-17.86%
0%
-17.86%
4 Years
-7.13%
0%
-7.13%
5 Years
13.15%
0%
13.15%
Jiuzhitang Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-11.36%
EBIT Growth (5y)
-21.52%
EBIT to Interest (avg)
89.35
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.63
Tax Ratio
16.30%
Dividend Payout Ratio
117.97%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.18%
ROE (avg)
7.04%
Valuation key factors
Factor
Value
P/E Ratio
52
Industry P/E
Price to Book Value
2.36
EV to EBIT
59.52
EV to EBITDA
30.70
EV to Capital Employed
2.73
EV to Sales
4.07
PEG Ratio
NA
Dividend Yield
2.99%
ROCE (Latest)
4.58%
ROE (Latest)
4.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
601.80
362.90
65.83%
Operating Profit (PBDIT) excl Other Income
113.90
31.40
262.74%
Interest
0.30
0.40
-25.00%
Exceptional Items
0.40
0.00
Consolidate Net Profit
93.60
12.50
648.80%
Operating Profit Margin (Excl OI)
136.60%
-0.90%
13.75%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 65.83% vs -19.14% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 648.80% vs -60.57% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,206.80
2,351.00
-6.13%
Operating Profit (PBDIT) excl Other Income
373.60
294.50
26.86%
Interest
1.60
2.80
-42.86%
Exceptional Items
0.40
0.00
Consolidate Net Profit
259.60
215.20
20.63%
Operating Profit Margin (Excl OI)
112.00%
73.20%
3.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.13% vs -19.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 20.63% vs -27.25% in Dec 2024
About Jiuzhitang Co., Ltd. 
Jiuzhitang Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






